Drug and Medication Analysis & Statistics, July 2014 (p10)

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: drug, vaccine, smoking cessation, more »

271-310 of about 4 500 reports

Purchase Reports From Reputable Market Research Publishers

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2014

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors -Pipeline Insights, 2014

Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Monoamine Oxidase Inhibitors (MAOIs) -Pipeline Insights, 2014

Monoamine Oxidase Inhibitors (MAOIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Monoamine Oxidase Inhibitors (MAOIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
MT-1 Melatonin Receptor Agonists -Pipeline Insights, 2014

MT-1 Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“MT-1 Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2014

MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“MT-2 Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Nicotinic Agonists -Pipeline Insights, 2014

Nicotinic Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Nicotinic Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Norepinephrine-Dopamine Reuptake Inhibitors (NDRI) -Pipeline Insights, 2014

Norepinephrine-Dopamine Reuptake Inhibitors (NDRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Norepinephrine-Dopamine Reuptake Inhibitors (NDRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Opioid Receptor Agonist -Pipeline Insights, 2014

Opioid Receptor Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Opioid Receptor Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Opioid Receptor Antagonists -Pipeline Insights, 2014

Opioid Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Opioid Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Parathyroid Hormone Receptor Agonist -Pipeline Insights, 2014

Parathyroid Hormone Receptor Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Parathyroid Hormone Receptor Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Penicillin-Binding Proteins (PBPs) Inhibitors -Pipeline Insights, 2014

Penicillin-Binding Proteins (PBPs) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Penicillin-Binding Proteins (PBPs) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Poly Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors -Pipeline Insights, 2014

Poly Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Poly Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Progesterone Receptor (PR) Antagonists -Pipeline Insights, 2014

Progesterone Receptor (PR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Progesterone Receptor (PR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Progesterone Receptor Agonists -Pipeline Insights, 2014

Progesterone Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Progesterone Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication
Selective Glucocorticoid Receptor Agonists -Pipeline Insights, 2014

Selective Glucocorticoid Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective Glucocorticoid Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Selective Serotonin Reuptake Inhibitors (SSRI) -Pipeline Insights, 2014

Selective Serotonin Reuptake Inhibitors (SSRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective Serotonin Reuptake Inhibitors (SSRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2014

Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin (5-HT) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin (5-HT) Receptor Antagonists -Pipeline Insights, 2014

Serotonin (5-HT) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin (5-HT) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin Reuptake Inhibitors (SRI) -Pipeline Insights, 2014

Serotonin Reuptake Inhibitors (SRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin Reuptake Inhibitors (SRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin Transporter Inhibitors -Pipeline Insights, 2014

Serotonin Transporter Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin Transporter Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin-Norepinephrine Reuptake Inhibitors(SNRI) -Pipeline Insights, 2014

Serotonin-Norepinephrine Reuptake Inhibitors(SNRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin-Norepinephrine Reuptake Inhibitors(SNRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI) -Pipeline Insights, 2014

Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug and Medication
Somatostatin Receptor Agonist -Pipeline Insights, 2014

Somatostatin Receptor Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Somatostatin Receptor Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists -Pipeline Insights, 2014

Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights ...

  • Industries : Drug and Medication
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists -Pipeline Insights, 2014

Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights ...

  • Industries : Drug and Medication
Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2014

Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Voltage-Dependent Calcium Channel Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Voltage-Dependent N-Type Calcium Channel Blockers -Pipeline Insights, 2014

Voltage-Dependent N-Type Calcium Channel Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Voltage-Dependent N-Type Calcium Channel Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2014

Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Voltage-Dependent T-Type Calcium Channel Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Glucocorticoid Receptor II (GR-II) Antagonists -Pipeline Insights, 2014

Glucocorticoid Receptor II (GR-II) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucocorticoid Receptor II (GR-II) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Bladder Cancer Drug Pipeline Update 2014

Bladder Cancer Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

  • Industries : Drug and Medication
About 15 000 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Market in the US

  • Grand Rounds
  • September 2014
    4 pages
  • Drug And Medica...  

    Drug  

  • United States  

View report >

Drug Demand In Europe

August 2014

82 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.